Concepedia

Mary Ann McElligott

MA

Statistics

Publications

9

Citations

671

H-Index

9

Active since

1981

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Harvard University

Mary Ann McElligott is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, biochemistry, and protein turnover.

Publications per year

1981–1998

9

Publications

9

A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension

R. Alan Wright, Horacio Kaufmann, Rafael Perera et al. · Neurology · 1998 · 333 citations

, , +13

Histidine and Proline are Important Sites of Free Radical Damage to Proteins

Roger T. Dean, Simon P. Wolff, Mary Ann McElligott · Free Radical Research Communications · 1989 · 86 citations

, , +17

Lysosomal degradation of ribonuclease A and ribonuclease S-protein microinjected into the cytosol of human fibroblasts.

Mary Ann McElligott, Pengfei Miao, J. Fred Dice · Journal of Biological Chemistry · 1985 · 65 citations · Full text

, , +16

Effect of continuous and intermittent clenbuterol feeding on rat growth rate and muscle

Mary Ann McElligott, Chaung Lee-Yuh · Comparative Biochemistry and Physiology Part C Comparative Pharmacology · 1989 · 54 citations

, , +10

Midodrine treatment for patients with hemodialysis hypotension.

John J. Flynn, Mary Mitchell, Frank Caruso et al. · PubMed · 1996 · 46 citations

, , +17

1–5 of 9